150 related articles for article (PubMed ID: 28105133)
1. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y
Exp Ther Med; 2016 Dec; 12(6):4017-4024. PubMed ID: 28105133
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Campone M; Berton-Rigaud D; Joly-Lobbedez F; Baurain JF; Rolland F; Stenzl A; Fabbro M; van Dijk M; Pinkert J; Schmelter T; de Bont N; Pautier P
Oncologist; 2013; 18(11):1190-1. PubMed ID: 24105751
[TBL] [Abstract][Full Text] [Related]
4. Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.
Li S; Chen X; Li Q; Du J; Liu Z; Peng Y; Xu M; Li Q; Lei M; Wang C; Zheng S; Zhang X; Yu H; Shi J; Tao S; Feng P; Tian H
J Diabetes Investig; 2016 Sep; 7(5):777-85. PubMed ID: 27180954
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
Parisi S; Ditto MC; Borrelli R; Fusaro E
Minerva Med; 2021 Aug; 112(4):492-499. PubMed ID: 34056884
[TBL] [Abstract][Full Text] [Related]
7. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
Hershman DL; Unger JM; Crew KD; Till C; Greenlee H; Minasian LM; Moinpour CM; Lew DL; Fehrenbacher L; Wade JL; Wong SF; Fisch MJ; Lynn Henry N; Albain KS
J Natl Cancer Inst; 2018 Jun; 110(6):669-676. PubMed ID: 29361042
[TBL] [Abstract][Full Text] [Related]
8. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine.
Ghirardi O; Vertechy M; Vesci L; Canta A; Nicolini G; Galbiati S; Ciogli C; Quattrini G; Pisano C; Cundari S; Rigamonti LM
In Vivo; 2005; 19(3):631-7. PubMed ID: 15875786
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review.
Di Stefano G; Di Lionardo A; Galosi E; Truini A; Cruccu G
J Pain Res; 2019; 12():1341-1351. PubMed ID: 31118753
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
[TBL] [Abstract][Full Text] [Related]
12. A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease.
Yang Y; Choi H; Lee CN; Kim YB; Kwak YT
Dement Neurocogn Disord; 2018 Mar; 17(1):1-10. PubMed ID: 30906386
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.
Li S; Li Q; Li Y; Li L; Tian H; Sun X
PLoS One; 2015; 10(3):e0119479. PubMed ID: 25751285
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.
Beghi E; Pupillo E; Bonito V; Buzzi P; Caponnetto C; Chiò A; Corbo M; Giannini F; Inghilleri M; Bella VL; Logroscino G; Lorusso L; Lunetta C; Mazzini L; Messina P; Mora G; Perini M; Quadrelli ML; Silani V; Simone IL; Tremolizzo L;
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):397-405. PubMed ID: 23421600
[TBL] [Abstract][Full Text] [Related]
15. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F
Am J Clin Nutr; 2011 Apr; 93(4):799-808. PubMed ID: 21310833
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.
Bianchi G; Vitali G; Caraceni A; Ravaglia S; Capri G; Cundari S; Zanna C; Gianni L
Eur J Cancer; 2005 Aug; 41(12):1746-50. PubMed ID: 16039110
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
Flatters SJ; Xiao WH; Bennett GJ
Neurosci Lett; 2006 Apr; 397(3):219-23. PubMed ID: 16406309
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial.
Curran MW; Olson J; Morhart M; Sample D; Chan KM
Trials; 2016 Apr; 17():200. PubMed ID: 27079660
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
[TBL] [Abstract][Full Text] [Related]
20. Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.
Guo L; Pan Q; Cheng Z; Li Z; Jiang H; Zhang F; Li Y; Qiu W; Lu S; Tian J; Fu Y; Li F; Li D
Diabetes; 2024 May; 73(5):797-805. PubMed ID: 38320260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
